Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

Antimüllerian Hormone as a Predictor of Future Infertility Risk in Prepubertal/Pubertal Cancer Patients

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT02595255
Title field or adapter rule
protocolSection.identificationModule.officialTitle
Ingested At
2026-04-28T10:37:43.492740+00:00
Published At
2020-05-04T00:00:00+00:00
Record Updated At
2020-05-04
Timestamp Basis
source retrieval time was not retained by the feed adapter
Date limitation
source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["Fertility Preservation", "Lymphoma", "Pediatrics Cancer", "Gonadotropin-releasing Hormone Agonist"]
protocolSection.statusModule.lastUpdatePostDateStruct.date
"2020-05-04"
protocolSection.identificationModule.nctId
"NCT02595255"
protocolSection.identificationModule.officialTitle
"Antim\u00fcllerian Hormone as a Predictor of Future Infertility Risk in Prepubertal/Pubertal Cancer Patients"
protocolSection.statusModule.overallStatus
"RECRUITING"
protocolSection.designModule.phases
[]
protocolSection.statusModule.resultsFirstPostDateStruct.date
""

Study condition terms

  • Fertility Preservation (protocolSection.conditionsModule.conditions)
  • Lymphoma (protocolSection.conditionsModule.conditions)
  • Pediatrics Cancer (protocolSection.conditionsModule.conditions)
  • Gonadotropin-releasing Hormone Agonist (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.